| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Yoshibayashi M, Kamiya T. Saito Y. Nakao K, Nishioka K, Temma S, Itoh H, Shirakami G, Matsuo H. Plasma brain natriuretic peptide concentrations in healthy children from birth to adolescence: marked and rapid increase after birth. Eur J Endocrinol 1995;133:207–9. ISSN 0804–4643
The aim of the present study is to establish the normal range and to determine the developmental changes of plasma brain natriuretic peptide (BNP) concentrations in children. We measured plasma BNP concentrations as well as atrial natriuretic peptide (ANP) concentrations in 58 healthy children from birth to adolescence and in the umbilical vein of 20 healthy neonates using highly sensitive immunoradiometric assays. The plasma BNP concentration was the highest at 0 days of age and descended through maturation to be almost constant and to be at the adult level at 3 months of age. The plasma BNP concentration at 0 days of age (56.7 ± 49.6 fmol/ml; mean±SD) was 25 to 30 times higher than the adult level and 21 times higher than that in the umbilical vein (2.7 ± 1.4fmol/ml), The plasma ANP concentration at 0 days of age was not significantly different from that in the umbilical vein. The ratio of BNP to ANP was also the highest at 0 days of age (1.39 ± 0.72) and decreased through maturation to be at the adult level at 3 months of age. Thus, the plasma BNP concentration in healthy subjects showed a marked, rapid and preferential increase immediately after birth, suggesting that BNP has a physiological role distinct from that of ANP in the perinatal circulatory changes from fetus to neonate.
Muneo Yoshibayashi, Department of Pediatrics, National Cardiovascular Center, 5-7-1 Fujishirodai, Suita, Osaka 565, Japan
This article has been cited by other articles:
|
|
 |
|
  J.-H. Hsu, R. L. Keller, O. Chikovani, H. Cheng, S. A. Hollander, T. R. Karl, A. Azakie, I. Adatia, P. Oishi, and J. R. Fineman B-type natriuretic peptide levels predict outcome after neonatal cardiac surgery. J. Thorac. Cardiovasc. Surg., October 1, 2007; 134(4): 939 - 945. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Cannesson, C. Bionda, B. Gostoli, O. Raisky, S. di Filippo, D. Bompard, C. Vedrinne, R. Rousson, J. Ninet, J. Neidecker, et al. Time Course and Prognostic Value of Plasma B-type Natriuretic Peptide Concentration in Neonates Undergoing the Arterial Switch Operation Anesth. Analg., May 1, 2007; 104(5): 1059 - 1065. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. F. Price, A. K. Thomas, M. Grenier, B. W. Eidem, E. O. Smith, S. W. Denfield, J. A. Towbin, and W. J. Dreyer B-Type Natriuretic Peptide Predicts Adverse Cardiovascular Events in Pediatric Outpatients With Chronic Left Ventricular Systolic Dysfunction Circulation, September 5, 2006; 114(10): 1063 - 1069. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Dodge-Khatami, E. V. Buchel, W. Knirsch, A. Kadner, V. Rousson, H. H. Dave, U. Bauersfeld, and R. Pretre Brain natriuretic peptide and magnetic resonance imaging in tetralogy with right ventricular dilatation. Ann. Thorac. Surg., September 1, 2006; 82(3): 983 - 988. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. da Graca, D. C. Hassinger, P. A. Flynn, C. P. Sison, M. Nesin, and P. A.M. Auld Longitudinal changes of brain-type natriuretic Peptide in preterm neonates. Pediatrics, June 1, 2006; 117(6): 2183 - 2189. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Costello, C. L. Backer, P. A. Checchia, C. Mavroudis, R. G. Seipelt, and D. M. Goodman Effect of cardiopulmonary bypass and surgical intervention on the natriuretic hormone system in children J. Thorac. Cardiovasc. Surg., September 1, 2005; 130(3): 822 - 829. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. M. Choi, K. H. Lee, B. L. Eun, K. H. Yoo, Y. S. Hong, C. S. Son, and J. W. Lee Utility of Rapid B-Type Natriuretic Peptide Assay for Diagnosis of Symptomatic Patent Ductus Arteriosus in Preterm Infants Pediatrics, March 1, 2005; 115(3): e255 - e261. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. W. Reynolds, J. G. Ellington, M. Vranicar, and H. S. Bada Brain-Type Natriuretic Peptide in the Diagnosis and Management of Persistent Pulmonary Hypertension of the Newborn Pediatrics, November 1, 2004; 114(5): 1297 - 1304. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Ootaki, M. Yamaguchi, N. Yoshimura, S. Oka, M. Yoshida, and T. Hasegawa Secretion of A-type and B-type natriuretic peptides into the bloodstream and pericardial space in children with congenital heart disease J. Thorac. Cardiovasc. Surg., November 1, 2003; 126(5): 1411 - 1416. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Rauh and A. Koch Plasma N-Terminal Pro-B-Type Natriuretic Peptide Concentrations in a Control Population of Infants and Children Clin. Chem., September 1, 2003; 49(9): 1563 - 1564. [Full Text] [PDF]
|
|
|
|
 |
|
 A Koch and H Singer Normal values of B type natriuretic peptide in infants, children, and adolescents Heart, August 1, 2003; 89(8): 875 - 878. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. S. Mir, S. Marohn, S. Laer, M. Eiselt, O. Grollmus, and J. Weil Plasma Concentrations of N-Terminal Pro-Brain Natriuretic Peptide in Control Children From the Neonatal to Adolescent Period and in Children With Congestive Heart Failure Pediatrics, December 1, 2002; 110(6): e76 - 76. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Valsson, S. Lundin, K. Kirno, T. Hedner, E. Houltz, Y. Saito, and S.-E. Ricksten Atrial Natriuretic Peptide Attenuates Pacing-Induced Myocardial Ischemia During General Anesthesia in Patients with Coronary Artery Disease Anesth. Analg., February 1, 1999; 88(2): 279 - 279. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
